Pricing Log in Create free account

Alector, Inc. (ALEC) vs Larimar Therapeutics, Inc. (LRMR)

Alector, Inc. and Larimar Therapeutics, Inc. are both Biotechnology companies. Alector, Inc. and Larimar Therapeutics, Inc. are of similar size ($213.3M and $206.7M). Larimar Therapeutics, Inc. has the higher net margin (0.00% vs −850.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Alector, Inc. leads on 6 and Larimar Therapeutics, Inc. on 6.

Valuation

Metric ALEC LRMR Biotechnology median
P/E n/m n/m 8.50
P/S 14.76 n/m 9.71
P/B n/m 1.62 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.61 n/m 9.21
Earnings yield (59.78%) (97.99%) (33.15%)
Free cash flow yield (77.40%) (75.51%) (25.50%)

Profitability

Metric ALEC LRMR Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (912.40%) 0.00% 0.00%
Net margin (850.13%) 0.00% 0.00%
Free cash flow margin (1,142.55%) 0.00% 0.00%
Return on equity (385.11%) (138.41%) (56.36%)
Return on assets (42.15%) (108.53%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC LRMR Biotechnology median
Revenue growth (TTM) (82.91%) — 6.02%
EPS growth (last fiscal year) (13.01%) (71.97%) 30.26%
Revenue growth, 5-year CAGR (0.05%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALEC LRMR Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 5.26 4.70 4.72
Net debt to EBITDA 1.61 0.79 0.96

Dividend

Metric ALEC LRMR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALEC LRMR Biotechnology median
Market cap 213.27m 206.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack